← Back to Search

A Web-Based Cardiovascular Intervention for the Workplace

Phase 1
Waitlist Available
Led By Diane K. Deitz, PhD
Research Sponsored by National Heart, Lung, and Blood Institute (NHLBI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Works in participating company
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

Heart disease is the leading cause of death in the United States, accounting for approximately 700,000 deaths a year. Heart disease can take many forms, including heart attacks, coronary artery disease, aneurysms, high blood pressure, and strokes. However, people can change things in their life to reduce the risk of getting heart disease. This study will first create an Internet-based program to help teach people about reducing heart disease risk and will then test the program in a workplace setting.

Eligible Conditions
  • Cardiovascular Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Participants will use the Web-based Heart Healthy program.
Group II: 2Active Control1 Intervention
Participants will receive treatment as usual.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)Lead Sponsor
3,942 Previous Clinical Trials
47,792,938 Total Patients Enrolled
National Institute for Occupational Safety and Health (NIOSH/CDC)FED
43 Previous Clinical Trials
49,728 Total Patients Enrolled
Diane K. Deitz, PhDPrincipal InvestigatorISA Associates
~18 spots leftby Dec 2025